Illumina on Monday filed an appeal against a Federal Trade Commission (FTC) order, demanding that it divest cancer diagnostic test maker Grail over competition concerns in the U.S. market for cancer tests.
San Diego-based Illumina is arguing that the FTC "violated due process by depriving Illumina and Grail of a fair proceeding before an impartial tribunal," according to the filing in the U.S. Fifth Circuit Court of Appeals.ruled for a second time
The FTC has been concerned that Illumina, the dominant provider of DNA sequencing of tumors and cancer cells that help match patients with the best treatment option, might raise prices or refuse to sell to Grail's rivals. Illumina has pledged to continue selling its DNA sequencing services to other firms. It has offered to sign contracts to supply any of Grail's rivals and to not raise prices.In early December, EU antitrust regulators proposed measures for Illumina to unwind its acquisition of Grail, three months after blocking the deal.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Microsoft to pay $20 mln to settle US charges for violating children's privacyMicrosoft will pay $20 million to settle U.S. Federal Trade Commission (FTC) charges that the tech company illegally collected personal information from children without their parents' consent, the FTC said on Monday.
Read more »
Bay Area biotech firm Grail wrongly told hundreds of people they might have cancerGrail, a biotech firm that makes a blood test for detecting cancer, blamed the snafu on a technology glitch.
Read more »
Hundreds mistakenly told they might have cancer, test company Grail saysHundreds of people using the test company Grail were wrongly told they might have cancer, the company said in a statement Monday.
Read more »
Hundreds mistakenly told they might have cancer, test company Grail saysHundreds of people using the test company Grail, based in Menlo Park, were wrongly told they might have cancer, the company said in a statement Monday.
Read more »
Hundreds mistakenly told they might have cancer, test company Grail saysHundreds of people using the test company Grail were wrongly told they might have cancer, the company said in a statement Monday.
Read more »
Younger Generations are more Likely to Fall for a Scam According to the FTCMore people in their twenties fell for some online ruse than people in their seventies, according to the Federal Trade Commission.
Read more »